Prenatal Testing After 35: Screening, NIPT, CVS, and Amnio

Quick answer: prenatal testing after 35 usually means discussing both screening tests and diagnostic tests early in pregnancy. Screening tests, including first-trimester screening, quad screening, ultrasound, and cell-free DNA/NIPT, estimate the chance of certain chromosome conditions or birth defects. Diagnostic tests, such as chorionic villus sampling (CVS) and amniocentesis, can give a more definite answer for specific genetic conditions but are invasive. You can accept or decline testing after discussing your options with your OB-GYN, midwife, maternal-fetal medicine specialist, or genetic counselor.

Ads

Pregnancy after 35 can make prenatal testing feel loaded before the conversation even starts. Many women hear phrases like “advanced maternal age” and immediately wonder whether they need every test available. The more accurate framing is this: age can change risk discussions, but ACOG states that prenatal genetic screening and diagnostic testing options should be offered to all pregnant patients, regardless of age or baseline risk.

This guide explains what your provider may recommend, when common tests happen, what each test can and cannot tell you, and which questions help you make a decision that fits your values.

Screening Tests vs Diagnostic Tests

The most important distinction is whether a test estimates risk or gives a more definite diagnosis for a specific condition. A screening result can be reassuring or can show increased risk, but it does not diagnose a condition. A diagnostic test looks directly at fetal or placental cells and can answer certain genetic questions with much more certainty.

Test type	Examples	What it can tell you	What it cannot do
Screening	NIPT/cell-free DNA, first-trimester screening, quad screen, ultrasound findings	Whether the pregnancy appears more or less likely to have certain chromosome conditions or structural concerns	It cannot diagnose a condition and can have false positives or false negatives
Diagnostic	CVS, amniocentesis	Whether the fetus has specific chromosome or genetic conditions included in the test	It cannot predict every birth outcome or every possible health issue
Imaging	First-trimester ultrasound, anatomy ultrasound, high-resolution ultrasound	Dating, number of fetuses, anatomy, growth, and some structural concerns	It cannot rule out all genetic or developmental conditions

Ads

If you are already comparing prenatal testing with broader pregnancy care, start with Pregnancy After 35: Risks, Care, and What to Expect.

A Common Prenatal Testing Timeline After 35

Exact timing depends on your clinic, pregnancy dating, personal history, insurance coverage, and local test availability. Still, most prenatal testing conversations after 35 follow a pattern like this:

Timing	Common option	Why it may be discussed
First visit or before pregnancy	Carrier screening and family history review	Looks for inherited conditions that can matter before or during pregnancy
10+ weeks	Cell-free DNA screening, often called NIPT	Screens for common chromosome conditions using a blood sample from the pregnant patient
10-13 weeks	First-trimester screening and/or nuchal translucency ultrasound	Combines blood work and ultrasound findings to estimate risk for certain conditions
10-13 weeks	CVS	Diagnostic testing using placental tissue; done earlier than amniocentesis
15-20 weeks	Amniocentesis	Diagnostic testing using amniotic fluid and fetal cells
15-22 weeks	Quad screen	Blood test that screens for certain chromosome conditions and neural tube defects
18-22 weeks	Anatomy ultrasound	Checks fetal structures such as brain, spine, heart, abdomen, face, and limbs

You usually do not need every screening test at the same time. ACOG guidance notes that if screening is accepted, patients should generally have one prenatal screening approach rather than multiple screening tests performed simultaneously. Your provider can help you choose the approach that fits your pregnancy and what you want to know.

What Changes When You Are 35 or Older?

Age 35 is not a cliff. It is a clinical threshold that has historically been used because some risks, including certain chromosome conditions, rise with age. That does not mean something is wrong, and it does not mean testing is mandatory. It means your provider may spend more time explaining genetic screening, diagnostic testing, anatomy ultrasound, and whether any additional monitoring makes sense based on your full history.

ACOG’s pregnancy-after-35 guidance also emphasizes that screening and diagnostic testing should be discussed and offered to all pregnant people, not only those over 35. The difference is often the depth of counseling and how risk is explained.

For early pregnancy context, pair this with First Trimester After 35: What to Expect and What to Ask.

NIPT or Cell-Free DNA Screening

NIPT, also called cell-free DNA screening, is a blood test that analyzes small fragments of placental DNA circulating in the pregnant patient’s blood. ACOG describes cell-free DNA as the most sensitive and specific screening test for common fetal aneuploidies, but it is still a screening test. It is not the same as diagnostic testing.

NIPT can usually be done starting at 10 weeks. It commonly screens for trisomy 21, trisomy 18, trisomy 13, and sex chromosome differences, though exact panels vary. Some commercial panels screen for more conditions, but “more” does not always mean “more useful” for every pregnancy. Ask what the test includes, what it does not include, and how positive results are confirmed.

A positive NIPT result should usually be followed by diagnostic testing with CVS or amniocentesis before irreversible pregnancy decisions are made. A negative result can be reassuring, but it does not rule out every birth defect, chromosome issue, genetic condition, or structural concern.

First-Trimester Screening

First-trimester screening usually combines a maternal blood test with an ultrasound measurement called nuchal translucency. ACOG describes first-trimester screening as typically happening between 10 and 13 weeks, while the CDC describes first-trimester screening as occurring around 11 to 13 weeks. Clinics vary, so your provider will use your exact dating.

This screening can estimate risk for certain chromosome conditions and may flag ultrasound findings that need follow-up. If you choose NIPT, ask whether first-trimester ultrasound is still recommended for dating, viability, multiples, or other early information.

CVS: Earlier Diagnostic Testing

Chorionic villus sampling, or CVS, is a diagnostic test that takes a small sample of placental tissue. ACOG explains that CVS is generally done earlier than amniocentesis, between 10 and 13 weeks. This can matter for parents who want diagnostic information as early as possible.

Because CVS is invasive, your clinician should explain the benefits, limitations, and pregnancy-loss risk in the context of your pregnancy and the experience of the center performing the procedure. CVS does not screen for neural tube defects in the same way second-trimester screening or ultrasound can, so follow-up testing or imaging may still be part of care.

Amniocentesis: Diagnostic Testing After 15 Weeks

Amniocentesis is another diagnostic test. ACOG describes it as usually performed between 15 and 20 weeks, though timing can vary. During amniocentesis, a thin needle withdraws a small amount of amniotic fluid under ultrasound guidance. Cells in the fluid can be tested for chromosome or genetic conditions depending on which analysis is ordered.

Some people choose amniocentesis after an abnormal screening result. Others choose it because they want diagnostic information from the beginning rather than a risk estimate. The right choice depends on what you would do with the information, your tolerance for uncertainty, and your risk discussion with your care team.

The Anatomy Ultrasound Still Matters

Even if NIPT is low risk, the anatomy ultrasound remains important. ACOG’s current NIPT guidance says all patients should be offered a second-trimester ultrasound for fetal structural defects, ideally between 18 and 22 weeks. The CDC similarly describes the second-trimester ultrasound as usually completed around 18 to 20 weeks.

This scan can evaluate major structures such as the brain, spine, heart, abdomen, face, and limbs. It can also identify findings that may lead to additional imaging, fetal echocardiogram, maternal-fetal medicine consultation, or diagnostic testing. A normal anatomy scan is reassuring, but it does not guarantee that every condition has been ruled out.

What an Abnormal Screening Result Means

An abnormal screening result means the pregnancy has a higher estimated chance for the condition being screened. It does not mean the fetus definitely has that condition. The CDC notes that screening tests can sometimes be abnormal even when nothing is wrong, and less often can miss a problem that does exist.

If a screening result is abnormal, the next step is usually a detailed conversation about confirmatory diagnostic testing, ultrasound, genetic counseling, and what the numbers mean for your specific situation. Try to get the actual risk estimate, not only the words “positive” or “high risk.” A result of 1 in 50 and a result of 1 in 2 can feel similar emotionally but mean very different things clinically.

How to Decide Which Tests Fit You

Testing decisions are not only medical; they are personal. Some parents want as much information as possible as early as possible. Others prefer fewer tests unless ultrasound or history suggests a concern. Some want screening only. Some want diagnostic testing. Some decline genetic testing altogether. ACOG explicitly frames prenatal testing as a choice, not an obligation.

Before choosing, ask yourself what you want the result to help you do. Do you want reassurance? Time to prepare medically? Time to learn about a condition? A decision point about diagnostic testing? A plan for delivery at a hospital with specific neonatal support? Those answers can guide the test strategy better than age alone.

Questions to Ask Your Provider

Which prenatal screening options are available at this clinic?
Do you recommend NIPT, first-trimester screening, quad screening, or diagnostic testing in my case?
What conditions does this test screen for, and what does it not screen for?
If the result is positive or high risk, what would the next step be?
Would I meet with a genetic counselor before or after testing?
What are the risks of CVS or amniocentesis at the center where I would have the procedure?
Will insurance cover this test, and are there lower-cost options?
When should I schedule the anatomy ultrasound?

Frequently Asked Questions

Do I need prenatal genetic testing because I am over 35?

No. Testing should be offered and discussed, but it is your choice. Being 35 or older can make the conversation more detailed because some risks increase with age, but testing is not required just because of your age.

Is NIPT better than first-trimester screening?

NIPT is more sensitive and specific for common chromosome conditions than traditional serum screening, but it is still a screening test. It does not replace diagnostic testing when a definite answer is needed, and it does not evaluate all possible structural birth defects.

Can a normal NIPT result replace the anatomy scan?

No. NIPT screens for selected chromosome conditions. The anatomy ultrasound checks fetal structures and can identify concerns unrelated to the chromosome conditions included in NIPT.

What happens if my screening test is abnormal?

Your provider may recommend genetic counseling, detailed ultrasound, and diagnostic testing with CVS or amniocentesis. Ask for the actual risk estimate and what condition the test flagged before making decisions.

Key Takeaways

Prenatal testing after 35 usually includes a discussion of both screening and diagnostic options.
Screening tests estimate risk; diagnostic tests can confirm specific genetic or chromosome conditions.
NIPT can start around 10 weeks and is a strong screening option for common aneuploidies, but it is not diagnostic.
CVS is generally done around 10-13 weeks; amniocentesis is usually done from 15 weeks onward.
The anatomy ultrasound around 18-22 weeks still matters, even after low-risk screening results.
There is no single right testing path. Your values, pregnancy history, risk tolerance, and provider guidance all matter.

Sources

This content is for informational purposes only and does not constitute medical advice. Individual pregnancy risks and testing options vary. Always discuss prenatal testing, screening results, diagnostic procedures, and pregnancy decisions with a qualified healthcare provider.

About the Author

Emily Carter is a women’s health writer focused on fertility, pregnancy after 35, and hormonal transitions. She writes research-informed, non-alarmist content to help women prepare better questions for their healthcare providers.